Filtered By:
Source: Neurology
Condition: Disability

This page shows you your search results in order of date. This is page number 14.

Order by Relevance | Date

Total 221 results found since Jan 2013.

Comparing Semi-quantitative and Volumetric Measurements of MRI White Matter Hyperintensities: The Northern Manhattan Study (S62.007)
CONCLUSIONS: Our volumetric and visual rating measures of WMH were strongly correlated, but the volumetric measure was associated with more risk factors in this community-based sample. User-friendly WMH scales that capture vascular risk are needed to develop risk-prediction scores for WMH lesion burden.Study Supported by:Evelyn F. McKnight Brain Institute and NINDS (R37 NS 29993; K02 NS 059729)Disclosure: Dr. Oboudiyat has nothing to disclose. Dr. Gardener has nothing to disclose. Dr. Marquez has nothing to disclose. Dr. Sacco has nothing to disclose. Dr. DeCarli has received personal compensation in an editorial capacity ...
Source: Neurology - April 9, 2014 Category: Neurology Authors: Oboudiyat, C., Gardener, H., Marquez, C., Elkind, M., Sacco, R., DeCarli, C., Wright, C. Tags: Cerebrovascular Disease and Interventional Neurology: Cognitive and Behavioral Source Type: research

Hypertension in Rural Uganda: Findings from a Community-Based Screening Project (I10-1.010)
Conclusions: Hypertension is highly prevalent among adults living in rural Uganda. The extremely low awareness in this population highlights the need for improved access to screening and treatment for hypertension to reduce the burden of cardiovascular diseases. Additional research is needed to identify the leading determinants of hypertension in this population.Disclosure: Dr. Chin has nothing to disclose.
Source: Neurology - April 9, 2014 Category: Neurology Authors: Chin, J. Tags: The Global Burden of Neurological Diseases Poster Presentations Source Type: research

Helping Haiti: Addressing the Burden of Neurologic Disease (I10-2.004)
CONCLUSIONS: With this nationwide collaborative and interdisciplinary approach, we hope to have a dramatic impact on the perceptions and outcomes of neurologic disease and provide a continuous, but dynamic presence in Port au Prince, Haiti while training physicians, nurses, and other team members in global health perspectives.Disclosure: Dr. Santini has nothing to disclose. Dr. Alessi has received personal compensation for activities with CBS Radio, the National Football League Players Association, and Colonial Cooperative Care. Dr. Jones has nothing to disclose. Dr. Etienne has nothing to disclose. Dr. Hohler has nothing to disclose.
Source: Neurology - April 9, 2014 Category: Neurology Authors: Santini, V., Alessi, A., Jones, E., Etienne, M., Hohler, A. Tags: The Global Burden of Neurological Diseases Data Blitz Presentations Source Type: research

Delay in the Diagnosis of Basilar Artery Ischemic Stroke (S51.007)
Conclusions: Our results suggest that both pre-hospital and in-hospital processes cause substantial delays in the diagnosis of basilar artery stroke. Further investigation is warranted to confirm these results.Disclosure: Dr. Burns has nothing to disclose. Dr. Sestokas has nothing to disclose. Dr. Carr has nothing to disclose. Dr. Lau has nothing to disclose. Dr. Green has nothing to disclose. Dr. Cervantes-Arslanian has nothing to disclose. Dr. Salem has nothing to disclose. Dr. Kase has nothing to disclose.
Source: Neurology - April 9, 2014 Category: Neurology Authors: Burns, J., Sestokas, R., Carr, C., Lau, H., Green, D., Cervantes-Arslanian, A. M., Salem, R., Kase, C. Tags: Cerebrovascular Disease and Interventional Neurology: Large Vessel Atherosclerotic Disease Source Type: research

Long-term survival after ischemic stroke in patients with atrial fibrillation
Conclusions: Ischemic stroke approximately triples the mortality rate in patients with atrial fibrillation. This effect persists well beyond the immediate period poststroke and is strongly associated with disability after stroke. Stroke prevention by anticoagulation has even greater beneficial effects on survival than usually considered when focusing solely on 30-day mortality rates.
Source: Neurology - March 24, 2014 Category: Neurology Authors: Fang, M. C., Go, A. S., Chang, Y., Borowsky, L. H., Pomernacki, N. K., Udaltsova, N., Singer, D. E. Tags: Outcome research, Stroke prevention, Cardiac, Cohort studies, Infarction ARTICLE Source Type: research

A decade of racial and ethnic stroke disparities in the United States
Stroke is the fourth leading cause of death and the leading cause of long-term disability in the United States. Stroke incidence and prevalence is not uniform. It occurs more frequently in some geographical areas of the United States and the rates are higher in minority groups.1,2 Some proposed causes for these disparities include increased rate of vascular risk factors that disproportionally affect some minority groups, differential effect of hypertension on stroke risk across racial groups, lack of access to health care and other social determinants of health, suboptimal control of risk factors, and although lacking subs...
Source: Neurology - March 24, 2014 Category: Neurology Authors: Gutierrez, J., Williams, O. A. Tags: Other cerebrovascular disease/ Stroke, All Cerebrovascular disease/Stroke, Prevalence studies, Risk factors in epidemiology GLOBAL PERSPECTIVES Source Type: research

Sex differences in quality of life after ischemic stroke
Conclusion: Women have worse QOL than men up to 12 months after stroke, even after adjusting for important sociodemographic variables, stroke severity, and disability.
Source: Neurology - March 17, 2014 Category: Neurology Authors: Bushnell, C. D., Reeves, M. J., Zhao, X., Pan, W., Prvu-Bettger, J., Zimmer, L., Olson, D., Peterson, E. Tags: Quality of life, All Cerebrovascular disease/Stroke ARTICLE Source Type: research

Fitness, depression, and poststroke fatigue: Worn out or weary?
Each year, around 15 million people worldwide have a stroke. Of these, at least 5 million die, a third remain disabled, and the remainder make a good recovery.1 Yet more than half of all these 10 million survivors will have fatigue, one of the most debilitating, but least studied, poststroke symptoms. Poststroke fatigue (PSF) is a multifaceted phenomenon.2 It has been correlated with lowered mood, as well as being influenced by other factors, like age, sex, and cognition. Many researchers have demonstrated that the presence of fatigue negatively influences quality of life, return to work, and perhaps mortality.3,4 However,...
Source: Neurology - October 28, 2013 Category: Neurology Authors: Brodtmann, A., van de Port, I. G. L. Tags: All Cerebrovascular disease/Stroke, Depression EDITORIALS Source Type: research

National Stroke Registries: What can we learn from them?
Stroke is a major cause of long-term adult disability, death, and health care costs worldwide. This overwhelming burden on global health necessitates ongoing improvements in stroke management. Indeed, considerable progress in stroke care is evident nowadays, in part owing to better prevention and the increasing use of acute stroke units, urgent triage, multimodal CT- or MRI-based brain imaging, and IV and endovascular reperfusion therapy.
Source: Neurology - September 30, 2013 Category: Neurology Authors: Tanne, D., Koton, S., Bornstein, N. M. Tags: All Health Services Research, Outcome research, All Cerebrovascular disease/Stroke, All epidemiology GLOBAL PERSPECTIVES Source Type: research

IV tissue plasminogen activator use in acute stroke: What are neurologists thinking?
Stroke remains among the top 4 causes of death in the United States and, despite advances in inpatient care and rehabilitation, the leading cause of severe disability. Furthermore, despite being a proven effective therapy, tissue plasminogen activator (tPA) use remains dramatically low, in ~2% of all stroke patients in a community setting.1 In this issue of Neurology®, Shamy2 addresses the use of tPA in appropriate clinical settings and neurologists' rationale for their decisions. Given the mortality and morbidity associated with stroke, the data for substantial benefit with tPA use, and Food and Drug Administration ap...
Source: Neurology - September 23, 2013 Category: Neurology Authors: Boissy, A. R. Tags: All Cerebrovascular disease/Stroke EDITORIALS Source Type: research

Association of atrial fibrillation with mortality and disability after ischemic stroke
Conclusions: Older age and increased stroke severity explain most of the association between AF and poorer outcomes after acute ischemic stroke. Nonuse of oral anticoagulant therapy represents the most important modifiable care gap to mitigate the association between AF and poor outcomes after ischemic stroke.
Source: Neurology - August 26, 2013 Category: Neurology Authors: McGrath, E. R., Kapral, M. K., Fang, J., Eikelboom, J. W., O'Conghaile, A., Canavan, M., O'Donnell, M. J., On behalf of the Investigators of the Ontario Stroke Registry Tags: Clinical trials Observational study (Cohort, Case control), Cohort studies, Infarction ARTICLE Source Type: research

JURaSSiC: Accuracy of clinician vs risk score prediction of ischemic stroke outcomes
Conclusions: Clinicians with expertise in stroke performed poorly compared to a validated tool in predicting the outcomes of patients with an acute ischemic stroke. Use of the risk stroke outcome tool may be superior for decision-making following an acute ischemic stroke.
Source: Neurology - July 29, 2013 Category: Neurology Authors: Saposnik, G., Cote, R., Mamdani, M., Raptis, S., Thorpe, K. E., Fang, J., Redelmeier, D. A., Goldstein, L. B. Tags: Prognosis, All Cerebrovascular disease/Stroke ARTICLE Source Type: research

Incidence and prevalence of treated epilepsy among poor health and low-income Americans
Conclusions: The Medicaid population has a high incidence and prevalence of epilepsy, in an order of magnitude greater than that reported in the US general population. This indigent population carries a disproportionate amount of the epilepsy burden and deserves more attention for its health care needs and support services.
Source: Neurology - May 20, 2013 Category: Neurology Authors: Kaiboriboon, K., Bakaki, P. M., Lhatoo, S. D., Koroukian, S. Tags: Cohort studies, Prevalence studies, Incidence studies, All Epilepsy/Seizures ARTICLE Source Type: research

Hypertension at time of diagnosis and long-term outcome after childhood ischemic stroke
Conclusions: HPT is prevalent in children with IS in the first 3 days after diagnosis and is associated with increased risk of death. Larger prospective studies involving systematic recording of blood pressure are required to delineate the impact of HPT on risk of death or disability.
Source: Neurology - March 25, 2013 Category: Neurology Authors: Brush, L. N., Monagle, P. T., Mackay, M. T., Gordon, A. L. Tags: Childhood stroke, All Pediatric, Pediatric stroke; see Cerebrovascular Disease/ Childhood stroke ARTICLE Source Type: research

Outcomes of Thrombolytic Treatment for Acute Ischemic Stroke in Dialysis Dependant Patients in the United States (S02.003)
CONCLUSIONS: The three fold higher odds of in-hospital mortality associated with administration of IV thrombolytics in dialysis dependant patients who present with acute ischemic stroke warrants a careful assessment of risk benefit ratio in this population.Disclosure: Dr. Adil has nothing to disclose. Dr. Adil has nothing to disclose. Dr. Irfan has nothing to disclose. Dr. Chaudhry has nothing to disclose. Dr. ATACH Investigators has nothing to disclose.
Source: Neurology - February 14, 2013 Category: Neurology Authors: Tariq, N., Adil, M., Irfan, M., Chaudhry, S., Qureshi, A. Tags: S02 Acute Stroke Therapy Source Type: research